<DOC>
	<DOCNO>NCT01421992</DOCNO>
	<brief_summary>The purpose study determine whether methylphenidate effective treatment excessive daytime sleepiness due myotonic dystrophy type 1 ( DM1 ) .</brief_summary>
	<brief_title>Methylphenidate Myotonic Dystrophy Type 1</brief_title>
	<detailed_description>Myotonic dystrophy type 1 ( DM1 ) multisystemic disorder characterize muscle weakness , myotonia , involvement several system . Hypersomnolence one frequently report symptoms patient DM1 often lead handicap cessation employment withdrawal social activities.The current investigation represent prospective , double-blind , randomize , crossover , placebo-controlled study design evaluate efficacy methylphenidate treatment excessive daytime sleepiness ( EDS ) adult DM1 .</detailed_description>
	<mesh_term>Myotonic Dystrophy</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>adult Epworth score â‰¥ 10 Diagnosis myotonic dystrophy type 1 hypersensibility methylphenidate Pregnancy Patients receive drug interfere methylphenidate Cognitive impairment Sleep apnea</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>randomize</keyword>
	<keyword>double-blind</keyword>
	<keyword>crossover</keyword>
	<keyword>methylphenidate</keyword>
	<keyword>excessive daytime sleepiness</keyword>
</DOC>